ClinicalThought


Share

Program Content

Activities

  • PPAR-delta Agonist and PBC Diagnosis
    Investigational PPAR-delta Agonist for PBC Treatment and Race-based Considerations for PBC Diagnosis: Conference Coverage of AASLD
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2023

    Expires: December 05, 2024

  • Dual PPAR Agonist and Hyperlipidemia in PBC
    Investigational Dual PPAR Agonist, FXR Agonist With Fibrate, and Hyperlipidemia in People With PBC: Conference Coverage of AASLD
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2023

    Expires: December 06, 2024

  • FXR Agonist PBC Studies
    Selected FXR Agonist PBC Studies: Conference Coverage of AASLD
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 20, 2023

    Expires: December 19, 2024

Faculty

cover img faculity

Stuart C. Gordon, MD, FACP, FACG, AGAF, FAASLD

Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Director, GI/Hepatology Research
Henry Ford Health System
Detroit, Michigan

cover img faculity

Kris V. Kowdley, MD, FAASLD, FACP, FACG

Professor, Elson S. Floyd College of Medicine
Washington State University
Director, Liver Institute Northwest
Seattle, Washington

cover img faculity

Marlyn J. Mayo, MD

Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner

Supporters

Supported by an educational grant from CymaBay Therapeutics.

CymaBay Therapeutics